The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 261.50
Bid: 261.60
Ask: 261.80
Change: 0.80 (0.31%)
Spread: 0.20 (0.076%)
Open: 262.20
High: 262.80
Low: 259.10
Prev. Close: 260.70
MKS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

23 Jun 2020 18:11

RNS Number : 8535Q
Marks & Spencer Group PLC
23 June 2020
 

Director/PDMR Shareholding

Marks and Spencer Group plc (the 'Company') announces that on 23 June 2020 it was notified of the following transactions in the Company's Ordinary 25p shares undertaken by director / persons discharging managerial responsibility ('PDMRs'):

1. Performance Share Plan

Exercise of an award granted on 5 December 2016 under the Company's 2016 Performance Share Plan ('PSP'), of which 34% vested as disclosed in the Company's 2018/19 Annual Report and Accounts, and subsequent sale of shares to satisfy the tax and National Insurance liabilities arising as set out below.

2. Deferred Share Bonus Plan

Exercise of awards granted on 23 June 2017 under the Company's 2017 Deferred Share Bonus Plan ('DSBP') and subsequent sale of shares to satisfy the tax and National Insurance liabilities arising as set out below.

3. Restricted Share Plan

Exercise of an award granted on 18 June 2018 under the Company's Restricted Share Plan ('RSP'), of which 50% vested in June 2019 and 50% vested in June 2020, and subsequent sale of shares to satisfy the tax and National Insurance liabilities arising as set out below.

 

PDMR

 

 

Shares exercised on 23 June 2020

Shares sold to cover tax and NI

Shares retained by individual

S Rowe

287,118*

135,421

151,697

S Berendji

40,314

19,016

21,298

P Friston

40,314

19,015

21,299

S Machin

39,452

18,609

20,843

*196,374 shares exercised under 2016 Performance Share Plan and 90,744 shares exercised under 2017 Deferred Share Bonus Plan.

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

1. Performance Share Plan

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

S Rowe

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Exercise of 196,374 shares from the 2016 Performance Share Plan.

2. Subsequent sale of 92,621 shares acquired under the PSP award to cover the tax and NI liability, with 103,753 shares retained.

c)

Price(s) and volume(s)

1. Exercise

Price(s)

Volume(s)

Nil cost

196,374

2. Sale

Price(s)

Volume(s)

£1.1002

92,621

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

196,374

 £0.00

2. Sale

Price(s)

Volume(s)

Total

£1.1002

92,621

 £101,901.62

e)

Date of the transaction

2020-06-23

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

2. Deferred Share Bonus Plan

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

S Rowe

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Exercise of 90,744 shares from the 2017 Deferred Share Bonus Plan.

2. Subsequent sale of 42,800 shares acquired under the DSBP award to cover the tax and NI liability, with 47,944 shares retained.

c)

Price(s) and volume(s)

1. Exercise

Price(s)

Volume(s)

Nil cost

90,744

2. Sale

Price(s)

Volume(s)

£1.1002

42,800

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

90,744

 £0.00

2. Sale

Price(s)

Volume(s)

Total

£1.1002

42,800

 £47,088.56

e)

Date of the transaction

2020-06-23

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

S Berendji

2

Reason for the notification

a)

Position/status

PDMR (Retail, Operations & Property Director)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Exercise of 40,314 shares from the 2017 Deferred Share Bonus Plan.

2. Subsequent sale of 19,016 shares acquired under the DSBP award to cover the tax and NI liability, with 21,298 shares retained.

c)

Price(s) and volume(s)

1. Exercise

Price(s)

Volume(s)

Nil cost

40,314

2. Sale

Price(s)

Volume(s)

£1.1053

19,016

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

40,314

 £0.00

2. Sale

Price(s)

Volume(s)

Total

£1.1053

19,016

 £21,018.38

e)

Date of the transaction

2020-06-23

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

P Friston

2

Reason for the notification

a)

Position/status

PDMR (International Director)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Exercise of 40,314 shares from the 2017 Deferred Share Bonus Plan.

2. Subsequent sale of 19,015 shares acquired under the DSBP award to cover the tax and NI liability, with 21,299 shares retained.

c)

Price(s) and volume(s)

1. Exercise

Price(s)

Volume(s)

Nil cost

40,314

2. Sale

Price(s)

Volume(s)

£1.104

19,015

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

40,314

 £0.00

2. Sale

Price(s)

Volume(s)

Total

£1.104

19,015

 £20,992.56

e)

Date of the transaction

2020-06-23

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

3. Restricted Share Plan

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

S Machin

2

Reason for the notification

a)

Position/status

PDMR (Food Managing Director)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Exercise of 39,452 shares from a 2018 award under the Restricted Share Plan.

2. Subsequent sale of 18,609 shares acquired under the RSP award to cover the tax and NI liability, with 20,843 shares retained.

c)

Price(s) and volume(s)

1. Exercise

Price(s)

Volume(s)

Nil cost

39,452

2. Sale

Price(s)

Volume(s)

£1.0988

18,609

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

39,452

 £0.00

2. Sale

Price(s)

Volume(s)

Total

£1.0988

18,609

 £20,447.56

e)

Date of the transaction

2020-06-23

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDXLFLBQLBBBK
Date   Source Headline
7th Nov 20187:00 amRNSHalf-year Report
1st Nov 20185:49 pmRNSHolding(s) in Company
30th Oct 20182:47 pmRNSDirector/PDMR Shareholding
24th Oct 20185:03 pmRNSHolding(s) in Company
24th Oct 20183:19 pmRNSHolding(s) in Company
18th Oct 201812:34 pmRNSAppointment of corporate broker
3rd Oct 20183:01 pmRNSDirector/PDMR Shareholding
1st Oct 201810:30 amRNSDirectorate Change
1st Oct 20189:00 amRNSTotal Voting Rights
28th Sep 201810:52 amRNSDirector/PDMR Shareholding
17th Sep 20184:36 pmRNSDirector/PDMR Shareholding
4th Sep 201810:12 amRNSDirector/PDMR Shareholding
3rd Sep 20189:00 amRNSTotal Voting Rights
20th Aug 20185:37 pmRNSDirector/PDMR Shareholding
6th Aug 20185:16 pmRNSDirector/PDMR Shareholding
1st Aug 20189:00 amRNSTotal Voting Rights
31st Jul 20183:58 pmRNSDirector/PDMR Shareholding
30th Jul 20185:30 pmRNSDirector/PDMR Shareholding
30th Jul 201811:18 amRNSDirector/PDMR Shareholding
16th Jul 20183:49 pmRNSDirector/PDMR Shareholding
11th Jul 20184:25 pmRNSDirector/PDMR Shareholding
10th Jul 20185:05 pmRNSResult of AGM
2nd Jul 201810:41 amRNSBlock listing Interim Review
2nd Jul 20189:00 amRNSTotal Voting Rights
29th Jun 20185:19 pmRNSDirector/PDMR Shareholding
25th Jun 201811:54 amRNSDirector/PDMR Shareholding
19th Jun 20185:25 pmRNSDirector/PDMR Shareholding
12th Jun 201811:19 amRNSDirector Declaration
8th Jun 20185:23 pmRNSDirector/PDMR Shareholding
7th Jun 201812:09 pmRNSAnnual Financial Report
1st Jun 20189:17 amRNSDirector/PDMR Shareholding
1st Jun 20189:01 amRNSTotal Voting Rights
29th May 201811:00 amRNSDirectorate Change
23rd May 20187:00 amRNSFinal Results
21st May 20187:45 amRNSDirectorate Change
1st May 20189:14 amRNSDirector/PDMR Shareholding
1st May 20188:18 amRNSTotal Voting Rights
18th Apr 20183:09 pmRNSDirectorate Change
3rd Apr 20189:00 amRNSTotal Voting Rights
29th Mar 201810:35 amRNSDirector/PDMR Shareholding
1st Mar 20189:00 amRNSTotal Voting Rights
28th Feb 20183:44 pmRNSDirector/PDMR Shareholding
1st Feb 20182:25 pmRNSDirector/PDMR Shareholding
1st Feb 20182:22 pmRNSTotal Voting Rights
15th Jan 20185:36 pmRNSDirector/PDMR Shareholding
15th Jan 201810:49 amRNSDirector Declaration
12th Jan 20189:16 amRNSHolding(s) in Company
11th Jan 20187:00 amRNS3rd Quarter Results
10th Jan 20189:33 amRNSDirectorate Change
9th Jan 201811:04 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.